Trexquant Investment LP Sage Therapeutics, Inc. Transaction History

Trexquant Investment LP

$8.35 Billion
Q2 2025

A detailed history of Trexquant Investment LP transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 223,121 shares of SAGE stock, worth $1.94 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

223,121

Previous 633,625 64.79%

Holding current value

$1.94 Million

Previous $5.04 Million 59.62%

% of portfolio

0.02%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$6.38 - $9.3 $2.62 Million - $3.82 Million	-410,504 Reduced 64.79%	223,121 $2.03 Million
Q1 2025 May 14, 2025	BUY	$5.55 - $8.66 $2.71 Million - $4.23 Million	488,963 Added 338.0%	633,625 $5.04 Million
Q4 2024 Feb 12, 2025	SELL	$4.78 - $8.57 $148,175 - $265,661	-30,999 Reduced 17.65%	144,662 $785,000
Q3 2024 Nov 12, 2024	SELL	$7.02 - $13.08 $979,865 - $1.83 Million	-139,582 Reduced 44.28%	175,661 $1.27 Million
Q2 2024 Aug 13, 2024	BUY	$10.58 - $17.9 $3.04 Million - $5.14 Million	287,385 Added 1031.61%	315,243 $3.42 Million
Q1 2024 May 14, 2024	SELL	$18.62 - $26.95 $1.4 Million - $2.03 Million	-75,239 Reduced 72.98%	27,858 $522,000
Q4 2023 Feb 09, 2024	BUY	$17.1 - $22.26 $1.76 Million - $2.29 Million	103,097 New	103,097 $2.23 Million
Q4 2022 Feb 13, 2023	SELL	$32.2 - $43.61 $43,309 - $58,655	-1,345 Reduced 6.23%	20,249 $772,000
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $697,054 - $934,372	21,594 New	21,594 $846,000
Q1 2022 May 13, 2022	SELL	$30.71 - $45.71 $202,655 - $301,640	-6,599 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $244,558 - $310,878	6,599 New	6,599 $281,000
Q2 2020 Aug 07, 2020	SELL	$25.95 - $43.15 $646,077 - $1.07 Million	-24,897 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$26.15 - $77.24 $651,056 - $1.92 Million	24,897 New	24,897 $715,000
Q1 2019 May 13, 2019	SELL	$89.33 - $163.65 $193,310 - $354,138	-2,164 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$81.94 - $139.71 $111,356 - $189,865	-1,359 Reduced 38.58%	2,164 $207,000
Q3 2018 Nov 09, 2018	SELL	$138.11 - $169.04 $2.3 Million - $2.82 Million	-16,682 Reduced 82.56%	3,523 $498,000
Q2 2018 Aug 07, 2018	BUY	$140.36 - $175.76 $2.84 Million - $3.55 Million	20,205 New	20,205 $3.16 Million

Others Institutions Holding SAGE

# of Institutions

211

Shares Held

50M

Call Options Held

790K

Put Options Held

440K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $516M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Sage Therapeutics, Inc. Transaction History